Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
oral infigratinib
product1 mentionslast seen Oct 13, 2026
Small molecule FGFR3 inhibitor for treating achondroplasia and hypochondroplasia in children.
Relationships 10
- oral infigratinibapplies toachondroplasia treatment97% confidence1 source
- BridgeBio Pharmadevelopsoral infigratinib97% confidence1 source
- oral infigratinibdepends onFGFR3 inhibition96% confidence1 source
- oral infigratinibconforms toBreakthrough Therapy Designation95% confidence1 source
- oral infigratinibconforms toOrphan Drug designation95% confidence1 source
- oral infigratinibconforms toRare Pediatric Disease designation94% confidence1 source
- oral infigratinibconforms toFast Track Designation94% confidence1 source
- U.S. Food and Drug Administrationapprovesoral infigratinib92% confidence1 source
- oral infigratinibapplies tohypochondroplasia treatment90% confidence1 source
- European Medicines Agencyapprovesoral infigratinib88% confidence1 source
Relationship
oral infigratinibapplies tohypochondroplasia treatment
90% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1